510(k) Report

510(k) · Cleared

Cleared

Certa Dose PD Epinephrine 1mg/mL IM/SC Syringe

K160589510(k) TraditionalCleared Jan 19, 2017324-day reviewClass II21 CFR 880.5860

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Certa Dose, Inc. · PQX Epinephrine Syringe

Cleared on Jan 19, 2017 as substantially equivalent to K991758 (The Kendal Co., 1999) and 1 other predicate after a 324-day review. Its family tree reaches back 3 generations to 1982.

Decided
Jan 19, 2017
Review
324 days
Class
Class II
Product code
PQX
Recalls
None
Predicates
2

Its longest line of descent runs back 3 generations to K822083 (1982). 9 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by generation 1 generation back: 1 other ancestor2 generations back: 5 other ancestors K071630 · Terumo 31G Thinpro Insulin Syringe · Terumo Medical Corp. · 2007K992802 · Terumo U-100 Insulin Syringe · Terumo Medical Corp. · 1999K822083 · U-100 Insulin Syringe · Terumo Medical Corp. · 19820
  1. Root · 3 generations backK822083 U-100 Insulin SyringeTerumo Medical Corp. · 1982
  2. 2 generations backK992802 Terumo U-100 Insulin SyringeTerumo Medical Corp. · 1999
  3. 1 generation backK071630 Terumo 31G Thinpro Insulin SyringeTerumo Medical Corp. · 2007
  4. This deviceK160589 Certa Dose PD Epinephrine 1mg/mL IM/SC SyringeCerta Dose, Inc. · 2017
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K822083U-100 Insulin SyringeTerumo Medical Corp.1982—
−2K992802Terumo U-100 Insulin SyringeTerumo Medical Corp.1999—
−1K071630Terumo 31G Thinpro Insulin SyringeTerumo Medical Corp.2007—
0 (this device)K160589Certa Dose PD Epinephrine 1mg/mL IM/SC SyringeCerta Dose, Inc.2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198510
199210
199610
199810
199910
200010
FIG. 1 — Lineage of K160589, 1982–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PQX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K991758Monoject Insulin Syringe
Summary page 4
…ory Class: II Product Code: PQX, Epinephrine Syringe III. PREDICATE DEVICES Primary: Monoject 3/10mL U-100 Insulin Syringe w/ Attached 29 Gauge x ½” Needle, K991758 Secondary: Terumo® 31G ThinPro Insulin Syringe, K071630 Reference Device: UniTox® Syringe, K123710 Reference Device: BD Flu+ Syri…
The Kendal Co.1999—
*K071630Terumo 31G Thinpro Insulin Syringe
Summary page 4
…I. PREDICATE DEVICES Primary: Monoject 3/10mL U-100 Insulin Syringe w/ Attached 29 Gauge x ½” Needle, K991758 Secondary: Terumo® 31G ThinPro Insulin Syringe, K071630 Reference Device: UniTox® Syringe, K123710 Reference Device: BD Flu+ Syringe, K091377 IV. DEVICE DESCRIPTION The Certa Dose™…
Terumo Medical Corp.2007—
†K123710Unitox Botox SyringeBio-Med USA, Inc.2013—
†K091377BD Flu+ SyringeBecton, Dickinson & CO2009—

Also cleared against K991758: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 35 years and passes through 2 companies; a new generation was cleared every 9.5 years on median.
  • 3 of the 9 ancestors have a recall of any class.
  • 2 other devices also cite its predicate K991758.

How does its category compare?

All PQX devices

PQX Epinephrine Syringe: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · PQX

1in 2018

2017: 12018: 1
2007high 1 (2017) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PQX

Too few PQX 510(k)s in any year since 2007 to give a median.

Recalls per year · PQX

No recall names PQX since 2007.

Adverse event reports per year · PQX

27in 2025

2022: 12024: 202025: 27
2007high 27 (2025) · low 0 (2007)2025

MAUDE reports naming product code PQX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20171—00
20181—00
20190—00
20200—00
20210—00
20220—01
20230—00
20240—020
20250—027
20260—0—

What is it indicated for?

The Certa Dose™ PD Epinephrine 1 mg/mL IM/SC Syringe is intended for healthcare professionals to deliver epinephrine 1 mg/mL via intramuscular or subcutaneous injection for pediatric patients.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K160589: Certa Dose PD Epinephrine 1mg/mL IM/SC Syringe.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K160589

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026